Acordis Industrial Fibers Gmbh

Cellmed Ag

Herma Glöckner

Peter Geigle

Rudi Wollbeck

Horst-Dieter Lemke

Roland Reiner

Frank Thürmer

Friedrich Hauck

Christoph Zimmerer

The invention relates to the use of implantable microcapsules, or microparticles or gels produced from alginates that are crosslinked with bivalent or multivalent cations or that are uncrosslinked, for the treatment of skin defects such as e.g. wrinkles, for the treatment of gastro-oesophageal reflux, urinary incontinence and vesico-ureteral reflux.

Injectable crosslinked and uncrosslinked alginates and the use thereof in medicine and in cosmetic surgery

Membrane module for testing active substances in cells with an interior chamber ( ) which is limited by a lid ( ), a bottom ( ), and a side wall ( ) and a system of first capillary membranes ( ) and a system of second capillary membranes ( ) located therein and possibly additional systems of capillary membranes, whereby the capillary membranes in interior chamber ( ) are arranged in at least one flat layer parallel to bottom ( ) and in interior chamber ( ) in the extracapillary space a cell culture chamber is formed around the capillary membranes, whereby the capillary membranes have a lumen that can be filled with a fluid, are passing with at least one of its ends through the side wall ( ) of interior chamber ( ) and are embedded at this end separated by systems in a casting material ( ) so that interior chamber ( ) is sealed fluid-tight from the outside, and whereby the capillary membranes of each system are in a fluid connection with their lumens with an inlet device ( ) and/or an outlet device ( ), and whereby interior chamber ( ) has a volume between 0.1 and 5 cm .

Membrane module for testing active substances at cells

Growing community of inventors

Kleinwallstadt, Germany

Herma Glöckner